H. Lundbeck A/S (CPH:HLUN.B)
Denmark · Delayed Price · Currency is DKK 34.98
+0.12 (0.34%)
Aug 11, 2025, 10:06 AM CET
Paramount Global Revenue
H. Lundbeck had revenue of 6.24B DKK in the quarter ending March 31, 2025, with 17.91% growth. This brings the company's revenue in the last twelve months to 22.95B, up 13.87% year-over-year. In the year 2024, H. Lundbeck had annual revenue of 22.00B with 10.51% growth.
Revenue (ttm)
22.95B
Revenue Growth
+13.87%
P/S Ratio
1.46
Revenue / Employee
4.03M
Employees
5,707
Market Cap
33.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.00B | 2.09B | 10.51% |
| Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
| Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
| Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
| Dec 31, 2020 | 17.67B | 636.00M | 3.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 311.94B |
| Coloplast | 27.79B |
| Genmab | 22.30B |
| Demant | 22.42B |
| ALK-Abelló | 5.71B |
| Ambu A/S | 5.83B |
| Zealand Pharma | 55.69M |
| Bavarian Nordic | 6.23B |